Skip to main content

Lipocine Inc.

LPCN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001535955

In the last 90 days, Lipocine Inc. insiders filed 3 open-market purchases and 0 sales; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.

Holders of 5% or more of LPCN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lipocine Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of LPCN
HolderLatest formStakeChangeFirst filedLatest filingFiling
Squadron Capital Management LLC13G/A9.80%810.0K shares+3.60 ppfrom 6.20%Dec 23, 20254 filingsAug 14, 2026SEC
Ikarian Capital, LLC13G6.30%508.6K sharesNewMay 15, 20261 filingMay 15, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

10 Schedule 13D and 13G filings on Lipocine Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on LPCN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20261:01 PM ETSquadron Capital Management LLCand 3 others13G/A9.80%810.0K shares+3.60 ppfrom 6.20%Jun 30, 2026SEC
May 15, 20265:00 PM ETIkarian Capital, LLCand 1 other13G6.30%508.6K sharesNewMar 31, 2026SEC
May 15, 202611:55 AM ETSquadron Capital Management LLCand 3 others13G/A6.20%450.0K shares−3.30 ppfrom 9.50%Mar 31, 2026SEC
Feb 17, 202611:49 AM ETSquadron Capital Management LLCand 3 others13G/A9.50%530.0K shares+0.50 ppfrom 9.00%Dec 31, 2025SEC
Dec 23, 20253:49 PM ETSquadron Capital Management LLCand 3 others13G9.00%500.0K sharesNewDec 18, 2025SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 11, 2021Renaissance Technologies LLC13G/AOld format–––SEC
Feb 10, 2021Hudson Bay Capital Management LP13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13GOld format–New–SEC
Jan 5, 2021Sabby Management, LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Lipocine Inc. shares.

No Form 144 notices for Lipocine Inc. are on file.